Recent News

• 08.04.2026 - Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
• 08.04.2026 - Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
• 07.20.2026 - Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
• 06.09.2026 - Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
• 05.19.2026 - Iridex Reports First Quarter 2026 Financial Results
• 05.05.2026 - Iridex to Report First Quarter 2026 Financial Results on May 19, 2026
• 04.07.2026 - Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
• 03.26.2026 - Iridex Reports Fourth Quarter and Full Year 2025 Financial Results
• 03.12.2026 - Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
• 02.02.2026 - Iridex Announces Plans to Relocate Headquarters

Recent Filings

• 07.16.2026 - 8-K Current report
• 07.16.2026 - EX-99.1 EX-99.1
• 07.14.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.14.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.13.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 07.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.18.2026 - 8-K Current report
• 06.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.15.2026 - 4 Statement of changes in beneficial ownership of securities